Medtronic Seeking Preliminary Injunction Against J&J For MiniCrown Stent
This article was originally published in The Gray Sheet
Executive Summary
Medtronic AVE plans to ask the U.S. District Court of Delaware to hear a motion for a preliminary injunction against Johnson & Johnson to prohibit the continued manufacture, use and sale of J&JCordis division's MiniCrown stent delivery system.
You may also be interested in...
Medtronic To Appeal Stent Patent Ruling Backing Guidant, Pursue New Claim
Medtronic is continuing to pursue pending litigation against Guidant subsidiary Advanced Cardiovascular Systems, alleging the Multilink Duet and Solo coronary stents and Megalink peripheral stent infringe patents held by Medtronic, the company says.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.